Exenatide.
Davidson
Mayer B
MB
Charles R. Drew University, Los Angeles, California 90059, USA. madavids@cdrewu.edu
Bate
Guy
G
Kirkpatrick
Peter
P
D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology; D004334:Drug Administration Schedule; D017277:Drug Approval; D004359:Drug Therapy, Combination; D000077270:Exenatide; D006801:Humans; D040541:Marketing / Q000191:economics / Q000379:methods; D010455:Peptides / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration; D014688:Venoms / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use*
D010455:Peptides; D014688:Venoms; D000077270:Exenatide